Compositions and methods for isolation of circulating tumor cells (CTC)
US10941452B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2015 |
| Grant date | Mar 9, 2021 |
| Priority date | — |
| Expiry date | Oct 5, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/53
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method useful for identifying and isolating live circulating tumor cells is described. The method utilizes an adenoviral vector comprising a replication-competent adenovirus in which the E1 gene region is expressed under the control of a telomerase-specific promoter and further comprises a second expression cassette containing a marker protein, optionally fused to a detectable cell surface marker to permit detection of circulating tumor cells lacking cell surface markers. The method involves combining ex vivo a test sample from a patient suspected of having circulating tumor cells, an adenoviral probe system, and culture media for the cells. The test sample is incubated with the adenoviral system for a sufficient time to permit expression of the reporter protein. The marker gene expression can thereafter be quantitated and the marker-expressing cells may optionally be collected for further analysis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.